Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

The Shuman Law Firm Announces Filing Of Securities Class Action Lawsuit Against Abiomed Inc


Friday, 21 Dec 2012 03:22pm EST 

The Shuman Law Firm announced that a lawsuit seeking class action status has been filed in the U.S. District Court for the District of Massachusetts on behalf of purchasers of Abiomed, Inc (Abiomed or the Company) securities between August 5, 2011 and October 31, 2012, inclusive (the Class Period). On November 1, 2012, prior to the opening of the markets, Abiomed disclosed that the United States Attorney's Office for the District of Columbia was conducting an investigation into Abiomed's marketing and labeling of its Impella 2.5 system. As a result of this news, shares of Abiomed declined $6.31 per share, or 31.33%, to close on November 1, 2012 at $13.61, on heavy trading volume. 

Company Quote

26.07
0.02 +0.08%
2 Sep 2014